These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31588509)

  • 21. Identifying Driver Interfaces Enriched for Somatic Missense Mutations in Tumors.
    Ozturk K; Carter H
    Methods Mol Biol; 2019; 1907():51-72. PubMed ID: 30542990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic pan-cancer analysis of somatic allele frequency.
    Spurr L; Li M; Alomran N; Zhang Q; Restrepo P; Movassagh M; Trenkov C; Tunnessen N; Apanasovich T; Crandall KA; Edwards N; Horvath A
    Sci Rep; 2018 May; 8(1):7735. PubMed ID: 29769535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COSMIC: somatic cancer genetics at high-resolution.
    Forbes SA; Beare D; Boutselakis H; Bamford S; Bindal N; Tate J; Cole CG; Ward S; Dawson E; Ponting L; Stefancsik R; Harsha B; Kok CY; Jia M; Jubb H; Sondka Z; Thompson S; De T; Campbell PJ
    Nucleic Acids Res; 2017 Jan; 45(D1):D777-D783. PubMed ID: 27899578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. muTarget: A platform linking gene expression changes and mutation status in solid tumors.
    Nagy Á; Győrffy B
    Int J Cancer; 2021 Jan; 148(2):502-511. PubMed ID: 32875562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive elaboration of database resources utilized in next-generation sequencing-based tumor somatic mutation detection.
    Gao P; Zhang R; Li J
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):122-137. PubMed ID: 31265877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
    Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
    Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BioVLAB-mCpG-SNP-EXPRESS: A system for multi-level and multi-perspective analysis and exploration of DNA methylation, sequence variation (SNPs), and gene expression from multi-omics data.
    Chae H; Lee S; Seo S; Jung D; Chang H; Nephew KP; Kim S
    Methods; 2016 Dec; 111():64-71. PubMed ID: 27477210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
    Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
    Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer: hunting rare somatic mutations.
    Marx V
    Nat Methods; 2016 Mar; 13(4):295-9. PubMed ID: 27027586
    [No Abstract]   [Full Text] [Related]  

  • 35. ESTree db: a tool for peach functional genomics.
    Lazzari B; Caprera A; Vecchietti A; Stella A; Milanesi L; Pozzi C
    BMC Bioinformatics; 2005 Dec; 6 Suppl 4(Suppl 4):S16. PubMed ID: 16351742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting Somatic Mutations in Normal Cells.
    Dou Y; Gold HD; Luquette LJ; Park PJ
    Trends Genet; 2018 Jul; 34(7):545-557. PubMed ID: 29731376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
    Zhong X; Yang H; Zhao S; Shyr Y; Li B
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer subtype identification using somatic mutation data.
    Kuijjer ML; Paulson JN; Salzman P; Ding W; Quackenbush J
    Br J Cancer; 2018 May; 118(11):1492-1501. PubMed ID: 29765148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational Methods for Subtyping of Tumors and Their Applications for Deciphering Tumor Heterogeneity.
    Zhang S
    Methods Mol Biol; 2019; 1878():193-207. PubMed ID: 30378077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cancer Omics Atlas: an integrative resource for cancer omics annotations.
    Sun Q; Li M; Wang X
    BMC Med Genomics; 2018 Aug; 11(1):63. PubMed ID: 30089500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.